| Howard J Rolins, MD | |
|
400 W Camino Casa Verde, Green Valley, AZ 85614-1945 | |
| (520) 625-1760 | |
| (520) 648-1394 |
| Full Name | Howard J Rolins |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 34 Years |
| Location | 400 W Camino Casa Verde, Green Valley, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114903242 | NPI | - | NPPES |
| 447541 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 24625 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tucson Medical Center | Tucson, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tucson Physician Group Holdings Llc | 0547560070 | 103 |
News Archive
Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that it has entered into a technology integration and development agreement with Lydall, Inc..
In a recent review article published in the journal ACS Nano, interdisciplinary researchers from across the world evaluated the role of carbon-based nanomaterials (CBNs), such as fullerene, carbon dots, graphene, and their derivatives as promising alternatives to combat COVID-19 (coronavirus disease 2019) and other microbial infections.
Thoughts that lead to compulsive behavior in obsessive-compulsive disorder (OCD) correspond with physiological changes in the brain, according to a new case study. The article is published ahead of print in the Journal of Neurophysiology.
Atrix Laboratories, Inc. announced today the company received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for fluticasone propionate cream, 0.05%.
› Verified 1 days ago
| Entity Name | Tucson Physician Group Holdings Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356726939 PECOS PAC ID: 0547560070 Enrollment ID: O20151204001261 |
News Archive
Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that it has entered into a technology integration and development agreement with Lydall, Inc..
In a recent review article published in the journal ACS Nano, interdisciplinary researchers from across the world evaluated the role of carbon-based nanomaterials (CBNs), such as fullerene, carbon dots, graphene, and their derivatives as promising alternatives to combat COVID-19 (coronavirus disease 2019) and other microbial infections.
Thoughts that lead to compulsive behavior in obsessive-compulsive disorder (OCD) correspond with physiological changes in the brain, according to a new case study. The article is published ahead of print in the Journal of Neurophysiology.
Atrix Laboratories, Inc. announced today the company received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for fluticasone propionate cream, 0.05%.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Howard J Rolins, MD 2202 N Forbes Blvd, Tucson, AZ 85745-1412 Ph: (520) 625-1760 | Howard J Rolins, MD 400 W Camino Casa Verde, Green Valley, AZ 85614-1945 Ph: (520) 625-1760 |
News Archive
Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that it has entered into a technology integration and development agreement with Lydall, Inc..
In a recent review article published in the journal ACS Nano, interdisciplinary researchers from across the world evaluated the role of carbon-based nanomaterials (CBNs), such as fullerene, carbon dots, graphene, and their derivatives as promising alternatives to combat COVID-19 (coronavirus disease 2019) and other microbial infections.
Thoughts that lead to compulsive behavior in obsessive-compulsive disorder (OCD) correspond with physiological changes in the brain, according to a new case study. The article is published ahead of print in the Journal of Neurophysiology.
Atrix Laboratories, Inc. announced today the company received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for fluticasone propionate cream, 0.05%.
› Verified 1 days ago
Dr. Sivamurthy Kyathari, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 514 E Whitehouse Canyon Rd Ste 110, Green Valley, AZ 85614 Phone: 520-689-7030 Fax: 520-395-9796 | |
Rossa Khalaf, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 121 W Esperanza Blvd # 181, Green Valley, AZ 85614 Phone: 520-689-6992 Fax: 520-230-3310 | |
Dr. Marvin B Padnick, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 4475 S I 19 Frontage Rd Ste 255, Green Valley, AZ 85614 Phone: 520-393-4863 | |
Joy L Logan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4475 S L-19 Frontage Road, Suite 101, Green Valley, AZ 85614 Phone: 520-585-4590 Fax: 520-398-7540 | |
Dr. Fred P Mendoza, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1055 N. Lacanada Blvd, Suite 121, Green Valley, AZ 85614 Phone: 520-547-7770 Fax: 520-547-7775 | |
Ruben Calvillo, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1141 S La Canada Dr, Green Valley, AZ 85614 Phone: 520-694-3030 Fax: 520-694-3055 |